RNA-seq analysis of laryngeal and hypopharyngeal cancer
This cohort includes the RNA-seq analysis of the pretreatment tissue sample of a phase II clinical trial. The aim of this study is to assess the efficacy, toxicities, and the potential role of larynx preservation of induction chemotherapy combined with PD-1 inhibitor in locally advanced laryngeal and hypopharyngeal cancer.